The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
2,400 jobs Number of planned job losses
400 jobs Number of planned job creations
Announcement Date
28 August 2008
Employment effect (start)
1 September 2008
Foreseen end date
31 December 2008
Description
The pharmaceutical group UCB announced at the end of August its decision to specialize in a certain type of medicine that acts on the immune system and the nerve center.
As a result 2400 jobs worldwide will be cut, while the management announced the recruitment of 400 specialists in these two fields.
Jobs losses have been announced in Belgium. The management remains silent about other countries but announced some restructuration in Europe, Japan and the United States.
Sources
3 September 2008: L'Echo
Citation
Eurofound (2008), UCB, Internal restructuring in World, factsheet number 67063, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/67063.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
